Explore
Validate
Learn66774-1-Ig
antibody from Proteintech Group
Targeting: KCNQ2
BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66774-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- KCNQ2 antibody
- Antibody type
- Monoclonal
- Description
- KCNQ2 antibody (Cat. #66774-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, Pig, Mouse, Rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat, Porcine
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1D4A1
- Vial size
- 20ul, 150ul
Submitted references Impacted spike frequency adaptation associated with reduction of KCNQ2/3 exacerbates seizure activity in temporal lobe epilepsy.
Mir324 knockout regulates the structure of dendritic spines and impairs hippocampal long-term potentiation.
Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats.
Jiang S, Liu B, Lin K, Li L, Li R, Tan S, Zhang X, Jiang L, Ni H, Wang Y, Ding H, Hu J, Qian H, Ge R
Hippocampus 2024 Feb;34(2):58-72
Hippocampus 2024 Feb;34(2):58-72
Mir324 knockout regulates the structure of dendritic spines and impairs hippocampal long-term potentiation.
Parkins EV, Brager DH, Rymer JK, Burwinkel JM, Rojas D, Tiwari D, Hu YC, Gross C
Scientific reports 2023 Dec 8;13(1):21919
Scientific reports 2023 Dec 8;13(1):21919
Effect of allisartan on blood pressure and left ventricular hypertrophy through Kv1.5 channels in hypertensive rats.
Xu C, Zhao Z, Yuan W, Fengping Z, Zhiqiang Y, Xiaoqin Z
Clinical and experimental hypertension (New York, N.Y. : 1993) 2022 Apr 3;44(3):199-207
Clinical and experimental hypertension (New York, N.Y. : 1993) 2022 Apr 3;44(3):199-207
No comments: Submit comment
No validations: Submit validation data